Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Evaluate the Safety and Efficacy of Modafinil in Children and Adolescents With ADHD

ClinicalTrials.gov ID: NCT00214981

Public ClinicalTrials.gov record NCT00214981. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 28, 2026, 11:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 1-Year, Open-Label, Flexible-Dosage Study to Evaluate the Safety and Continued Efficacy of Modafinil (Film-coated Tablet Formulation) in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder (Followed by an Open-Ended Extension Period)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary objective of this study is to evaluate the safety of treatment with modafinil film-coated tablet.

Study identification

NCT ID
NCT00214981
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Cephalon
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
6 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2003 (Type not available)
Primary completion
Sep 2006 (Actual)
Completion
Sep 2006 (Actual)
Last update posted
Jul 26, 2012

2003 – 2006

United States locations

U.S. sites
57
U.S. states
33
U.S. cities
56
Facility City State ZIP Site status
University of Alabama Birmingh Birmingham Alabama 35025 —
Pivotal Research Center Mesa Arizona 85210 —
River Valley Neurology Fort Smith Arkansas 72901 —
Clinical Study Centers, LLC Little Rock Arkansas 72205 —
UCI Child Development Center Irvine California 92612 —
BMR HealthQuest San Diego California 92123 —
University of CA San Francisco San Francisco California 94143 —
Encompass Clinical Research Spring Valley California 91978 —
Alpine Clinical Research Boulder Colorado 80304 —
Sarkis Clinical Trials Gainesville Florida 32607 —
Amedica Research Inst. Hialeah Florida 33013 —
Children's Developmental Cente Maitland Florida 32751 —
Miami Research Associates Miami Florida 33173 —
Clinical Neuroscience Solution West Palm Beach Florida 33407 —
Child Neurology Assoc. Atlanta Georgia 30342 —
Mountainview Center for Resear Decatur Georgia 30033 —
Foothills Psychiatry Boise Idaho 83702 —
Consultants in Neurology, Ltd. Northbrook Illinois 60062 —
Midwest Neurology, Inc. Danville Indiana 46122 —
Cientifica at Prarie View Newton Kansas 67114 —
Vince and Associates Clinical Overland Park Kansas 66211 —
Kentucky Pediatric/Adult Resea Bardstown Kentucky 40004 —
Michael J. Rieser, MD Lexington Kentucky 40509 —
Pedia Research, LLC Owensboro Kentucky 42301 —
Four Rivers Clinical Research Paducah Kentucky 42003 —
Dolby Providers, Inc. New Orleans Louisiana 70128 —
NeuroScience, Inc. Bethesda Maryland 20814 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Clinical Neurophysiology Svcs Troy Michigan 48085 —
University of Nebraska Omaha Nebraska 68198-7630 —
Clinical Research Center of NV Las Vegas Nevada 89014 —
Radiant Research Las Vegas Las Vegas Nevada 89146-5611 —
CNS Research Institute Clementon New Jersey 08021 —
Children's Specialized Hospita Toms River New Jersey 08755 —
University of Buffalo Buffalo New York 14214 —
New York Psychiatric Inst New York New York 10032 —
University of Rochester Rochester New York 14642 —
North Carolina Neuropsychiatry Chapel Hill North Carolina 27514 —
North Carolina Neuropsychiatry Charlotte North Carolina 28209 —
Psychiatric Professional Servi Cincinnati Ohio 45267-0559 —
Pahl Pharmaceutical Research Oklahoma City Oklahoma 73118 —
OCCI Eugene Eugene Oregon 97401 —
Summit Research Network Inc. Portland Oregon 97210 —
OCCI, Inc. Salem Oregon 97309 —
CNS Research Institute PC Philadelphia Pennsylvania 19149 —
Primary Physicians Research Pittsburgh Pennsylvania 15241 —
Rhode Island Hospital Providence Rhode Island 02903 —
Clinical Neuroscience Solution Memphis Tennessee 38119 —
Vanderbilt University Medical Nashville Tennessee 37232 —
Dallas Pediatric Neurology Dallas Texas 75230 —
UT Health Science Center San Antonio Texas 78229-3900 —
Radiant Research Salt Lake Salt Lake City Utah 84107 —
Otter Creek Clinical Studies Burlington Vermont 05401 —
Monarch Research Associates Norfolk Virginia 23510 —
James A. Knutson, MD Kirkland Washington 98033 —
Pacific Institute of Mental He Seattle Washington 98133-9009 —
Marshfield Clinical Research Marshfield Wisconsin 54449 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00214981, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 26, 2012 · Synced Oct 28, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00214981 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →